Obesity is having an excessive amount of body fat that may impair health.
The primary cause is an energy imbalance between calories consumed and expended.
Treatment goals include addressing the principal cause of weight gain and focusing management on both weight loss and patient-centered health outcomes.
A multidisciplinary approach, that is a combination of dietary change, physical activity and behavioral modification, is recommended.
Obesity at any age in adulthood doubles the risk of having poor physical functioning in midlife, with body mass index gains over much of the life course and prolonged exposure to obesity contributing to the risk, according to a study.
Teens with severe obesity need not wait until they are adults to undergo Roux-en-Y gastric bypass, with 5-year follow-up data from a recent study showing that the bariatric procedure leads to substantial weight loss that is similar in magnitude in adolescents and adults.
The risk of nonvertebral fractures is dependent on type of bariatric surgery, with a higher risk in patients with severe obesity who undergo Roux-en-Y gastric bypass (RYGB) compared with adjustable gastric banding (AGB), according to a recent retrospective study.
Laparoscopic sleeve gastrectomy is useful for treating severe obesity in adolescents with cognitive impairment or developmental disability, according to a study, suggesting that bariatric surgery should be considered for young people, regardless of intellectual ability.
One anastomosis gastric bypass is as effective as the standard Roux-en-Y procedure in terms of weight loss and metabolic improvements 24 months after the surgery, according to the results of the open-label YOMEGA trial.
Oral supplementation with probiotics or synbiotics leads to a reduction in waist circumference of overweight or obese adults, although the effect size is small and may be clinically insignificant, according to the results of a systematic review and meta-analysis.
Long-term testosterone therapy in obese men with hypogonadism led to sustained weight loss and improvements in multiple anthropometric parameters, according to an observational study presented at ENDO 2019.
About one-third of individuals who achieved remission of type 2 diabetes (T2D) after losing weight with an intensive weight management programme sustained their remission at 2 years, according to long-term results of the DiRECT* trial.
In addition to an intensive weight loss programme, the use of continuous positive airway pressure (CPAP) could improve absolute weight loss in individuals with obesity and obstructive sleep apnoea (OSA), according to a study presented at ENDO 2019.
Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.